REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

05/06/2024 15:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240605:nRSE2745Ra&default-theme=true

RNS Number : 2745R  Hikma Pharmaceuticals Plc  05 June 2024

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging
managerial responsibilities

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                                            Said Darwazah
 2   Reason for the notification
 a)  Position/status                                                                 Executive Chairman
 b)  Initial notification /Amendment                                                 Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                                            Hikma Pharmaceuticals PLC
 b)  LEI                                                                             549300BNS685UXH4JI75
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument and identification  Description: Ordinary shares of 10 pence each
     code

                                                                                     ID Code: GB00B0LCW083
 b)  Nature of the transaction                                                       Grant of a pledge by the Executive Chairman over 820,416 Ordinary Shares of 10

                                                                               pence each in Hikma Pharmaceuticals PLC in favour of EFG Private Bank UK
                                                                                     Limited.
 c)  Price(s) and volume(s)                                                          Price(s): £0.00p

                                                                                     Volume(s): 820,416
 d)  Aggregated information                                                          Aggregated volume: 820,416

                                                                                     Price: £0.00p
 e)  Date of the transaction                                                         31 May 2024
 f)  Place of the transaction                                                        Outside a trading venue

 

Helen Middlemist
Group Company Secretary

 

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBXGDLDUGDGSU